On one hand, it is believed that modifications of the endolysosomal compartment in AD and DS are mostly linked to increased Aβ production as the amyloidogenic processing of APP occurs in the endosomal pathway (Koo and Squazzo, 1994; Botte et al., 2020). This evidence concerns the gene APP and Alzheimer disease.